Amends GS 90-94.1 to also allow the possession or use of hemp extract to treat autism, multiple sclerosis, Crohn's disease, or Mitochondrial disease, in addition to the already allowable treatment of intractable epilepsy.

Amends Article 5G of GS Chapter 90 as follows. Expands the purpose of the act so that it is to allow the use of hemp extract as an alternative treatment for intractable epilepsy, autism, multiple sclerosis, Crohn's disease, and Mitochondrial disease (was, only intractable epilepsy) and renames the act as the Alternative Treatment Act to reflect the expansion. Make conforming changes to the stated General Assembly findings. Makes additional conforming changes throughout the Article to reflect the expanded allowable uses.

Expands the definition of caregiver to also include a nurse employed by a licensed home health agency, and any other caregiver of a patient who meets the already specified criteria. Expands upon the items that must be included in the neurologist's statement that the caregiver must posses, to add a statement that the patient's condition has not responded to three or more treatment options overseen by the neurologist or by a physician with whom the neurologist has consulted about the patient's condition. Also expands on the statement to allow the patient to be examined and under the care of the neurologist or a physician who has consulted with the neurologist. Adds and defines the term physician.

Amends the information that must be contained in the database registry, to also require the name, address, and hospital affiliation of any physician with whom the neurologist consults about the patient's condition in making the recommendation for hemp extract treatment. Makes conforming changes.

Effective December 1, 2019.